Barclays Analysts Give The Clorox (CLX) a $131.00 Price Target

Barclays set a $131.00 price objective on The Clorox (NYSE:CLX) in a research report released on Friday. The brokerage currently has a hold rating on the stock.

A number of other equities analysts have also weighed in on the company. Bank of America upgraded The Clorox from an underperform rating to a neutral rating and set a $155.00 target price on the stock in a research note on Thursday, January 4th. Wells Fargo restated a hold rating and issued a $130.00 target price on shares of The Clorox in a research note on Wednesday, December 13th. Deutsche Bank started coverage on The Clorox in a research note on Wednesday, December 13th. They issued a hold rating and a $142.00 target price on the stock. Zacks Investment Research lowered The Clorox from a buy rating to a hold rating in a research note on Monday, January 22nd. Finally, Jefferies Group restated a hold rating and issued a $130.00 target price on shares of The Clorox in a research note on Wednesday, December 13th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have issued a buy rating to the company’s stock. The Clorox currently has a consensus rating of Hold and an average target price of $131.89.

How to Become a New Pot Stock Millionaire

CLX traded down $1.74 during trading on Friday, reaching $128.51. 950,370 shares of the company were exchanged, compared to its average volume of 1,007,540. The stock has a market capitalization of $16,854.87, a price-to-earnings ratio of 24.02, a price-to-earnings-growth ratio of 2.70 and a beta of 0.35. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22. The Clorox has a 12-month low of $123.64 and a 12-month high of $150.40.

The Clorox (NYSE:CLX) last announced its earnings results on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.43 billion. The Clorox had a return on equity of 126.70% and a net margin of 13.21%. The company’s quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.14 EPS. research analysts forecast that The Clorox will post 5.66 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Stockholders of record on Wednesday, April 25th will be given a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 24th. This is a positive change from The Clorox’s previous quarterly dividend of $0.84. This represents a $3.84 annualized dividend and a dividend yield of 2.99%. The Clorox’s dividend payout ratio is 62.80%.

Several institutional investors have recently made changes to their positions in CLX. Nordea Investment Management AB increased its position in shares of The Clorox by 32.7% during the 3rd quarter. Nordea Investment Management AB now owns 8,772 shares of the company’s stock valued at $1,157,000 after purchasing an additional 2,163 shares during the last quarter. Commerzbank Aktiengesellschaft FI bought a new position in shares of The Clorox during the 3rd quarter valued at about $361,000. OxFORD Asset Management LLP bought a new position in shares of The Clorox during the 3rd quarter valued at about $2,092,000. Allianz Asset Management GmbH increased its position in shares of The Clorox by 417.8% during the 3rd quarter. Allianz Asset Management GmbH now owns 63,868 shares of the company’s stock valued at $8,425,000 after purchasing an additional 51,534 shares during the last quarter. Finally, AMP Capital Investors Ltd increased its position in shares of The Clorox by 8.9% during the 3rd quarter. AMP Capital Investors Ltd now owns 39,013 shares of the company’s stock valued at $5,146,000 after purchasing an additional 3,180 shares during the last quarter. Hedge funds and other institutional investors own 75.71% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Barclays Analysts Give The Clorox (CLX) a $131.00 Price Target” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/04/07/barclays-analysts-give-the-clorox-clx-a-131-00-price-target.html.

About The Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply